Medtronic plc announced that it has received U.S. FDA approval on an expanded indication for its Pipeline Flex embolization device. Previously indicated for the endovascular treatment of adults with large or giant wide-necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments, the new indication opens options for patients with small or medium, wide-necked brain aneurysms in the territory from the petrous to the terminus of the internal carotid artery.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.